Mirador Capital Partners LP Maravai Lifesciences Holdings, Inc. Transaction History

Mirador Capital Partners LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$26.05 - $37.48 $167,136 - $240,471	-6,416 Closed	0 $0
Q1 2022 May 06, 2022	SELL	$24.46 - $40.92 $189,344 - $316,761	-7,741 Reduced 54.68%	6,416 $226,000
Q4 2021 Feb 02, 2022	SELL	$35.0 - $45.94 $163,275 - $214,310	-4,665 Reduced 24.78%	14,157 $593,000
Q3 2021 Nov 09, 2021	BUY	$36.8 - $60.62 $692,649 - $1.14 Million	18,822 New	18,822 $924,000

235

141M

223K

19.4K

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $746M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

Get notified when there are updates to the investment portfolio of Mirador Capital Partners LP, based on Form 13F filings with the SEC.

Stay updated on Mirador Capital Partners LP with notifications on news.